Although IL-6, VEGF, and CA 125 all were elevated in ovarian cancer patients, and bFGF and M-CSF were decreased in these patients, only IL-6 and VEGF were significantly elevated in stagees I and II cancer patients. Here, FGF2 is linked to ovarian cancer.